Key facts
- This page summarizes Elaine Gangeri's Form 4 filing for Anterix Inc. (ATEX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 May 2021, 19:43.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Additional SEC filing notes
Footnote F1
The sale of shares was effected pursuant to a Rule 10b5-1 plan in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Footnote F2
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $47.12 to $48.65. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.